MedPhab, Europe’s first pilot line for photonics-based medical devices, has announced a call for proposals to support companies adopting photonics technologies for the development of new medical diagnostics solutions.
MedPhab offers modular technology blocks including photonics technologies, non-photonic peripherals, system integration and post-processing steps.
This modular concept enables a structured approach to highly fragmented heterogeneous photonic and non-photonic technologies such as microfluidics or surface functionalisation from early phase proof-of-concept to regulated pilot production.
The MedPhab open call provides financial support for different business sizes - European-based SMEs could receive a subsidy of 75 per cent of their innovation project, whereas large-scale European companies receive a 50 per cent subsidy.
The first cut-off date for expressing your interest is 15 July.
The photonics technologies offering within MedPhab comprises fibre optics, photonic reader modules, photonic integrated circuits, micro-optics and active components provided by parties with ISO13485 certification.
The technology offered by MedPhab can help companies to develop diagnostic solutions for hospital use to enable real-time information and monitoring of the treatment progression; novel home care services, and equipment for molecular diagnostics based on serum, saliva or urine samples.
MedPhab has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 871345.
